General Pathology — MCQs

General Pathology Indian Medical PG Practice Questions and MCQs

Question 1161: Which of the following is a feature of autosomal dominant disorders?

A. Typically presents early in life
B. Complete penetrance is common
C. New germline mutations occur in older fathers (Correct Answer)
D. Male-to-male transmission is not possible

Explanation: ### Explanation **Correct Option: C. New germline mutations occur in older fathers** In many autosomal dominant (AD) disorders (e.g., Achondroplasia, Marfan syndrome), a significant proportion of cases arise from **de novo mutations** rather than inheritance [2]. There is a well-documented correlation between **advanced paternal age** and the occurrence of these new germline mutations [2]. This is attributed to the fact that spermatogonia undergo continuous division throughout life, increasing the cumulative risk of DNA replication errors. **Analysis of Incorrect Options:** * **A. Typically presents early in life:** This is a characteristic of *Autosomal Recessive* (AR) disorders. AD disorders often have a **delayed onset** (e.g., Huntington’s disease, Adult Polycystic Kidney Disease), where symptoms appear later in clinical life [1], [3]. * **B. Complete penetrance is common:** AD disorders are frequently characterized by **reduced (incomplete) penetrance** (where an individual carries the gene but shows no phenotype) and **variable expressivity** (variation in the severity of the clinical features) [5]. * **D. Male-to-male transmission is not possible:** This is a feature of *X-linked* inheritance. In AD inheritance, the gene is located on an autosome; therefore, an affected father has a 50% chance of passing the trait to his son. **NEET-PG High-Yield Pearls:** * **Achondroplasia:** The most common AD disorder associated with advanced paternal age (mutation in *FGFR3*) [2]. * **Structural vs. Enzymatic:** AD disorders usually involve mutations in **structural proteins** (e.g., Collagen, Spectrin) or **receptors** (e.g., LDL receptor) [4]. In contrast, AR disorders usually involve **enzyme deficiencies** [4]. * **Pleiotropy:** A single mutation leading to multiple end-organ effects (e.g., Marfan syndrome affecting eyes, heart, and skeleton) is a hallmark of many AD conditions. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 149-150. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, pp. 1186-1188. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 148-149. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 57-58. [5] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, p. 147.

Question 1162: Which of the following is not seen in apoptosis?

A. Nuclear fragmentation
B. Cellular shrinkage
C. Inflammation (Correct Answer)
D. Alteration in cellular membrane structure

Explanation: Apoptosis is a form of programmed cell death characterized by a controlled, energy-dependent process that eliminates unwanted cells without eliciting an inflammatory response [1]. ### **Why Inflammation is not seen in Apoptosis** The hallmark of apoptosis is that the **plasma membrane remains intact**, although its structure is altered to signal phagocytes [1]. Because the membrane does not rupture, intracellular contents (such as lysosomal enzymes or DAMPs) are not leaked into the surrounding tissue. Furthermore, apoptotic cells are rapidly cleared by macrophages through "efferocytosis" before they can undergo secondary necrosis. This lack of leakage and rapid clearance prevents the recruitment of neutrophils and the subsequent inflammatory cascade, which is a defining feature of **Necrosis** [1]. ### **Analysis of Other Options** * **Nuclear fragmentation (Karyorrhexis):** This is a characteristic feature of apoptosis. The nucleus undergoes chromatin condensation (pyknosis) followed by fragmentation into small, membrane-bound vesicles. * **Cellular shrinkage:** Unlike necrosis where cells swell (oncosis), apoptotic cells shrink. The organelles become more tightly packed, and the cytoplasm becomes dense and eosinophilic. * **Alteration in cellular membrane structure:** While the membrane remains intact, its composition changes. Specifically, **Phosphatidylserine** flips from the inner leaflet to the outer leaflet ("eat-me" signal), allowing recognition by phagocytes [1]. ### **High-Yield NEET-PG Pearls** * **Gold Standard for Detection:** DNA Laddering (due to internucleosomal cleavage by endonucleases into 180-200 bp fragments). * **Most Characteristic Feature:** Chromatin condensation (Pyknosis). * **Key Enzyme:** Caspases (Cysteine-dependent Aspartate-specific proteases) [1]. * **Anti-apoptotic genes:** BCL-2, BCL-XL, MCL-1 [2]. * **Pro-apoptotic genes:** BAX, BAK [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 63-69. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 80-81.

Question 1163: Congo-red staining of amyloid produces which characteristic color?

A. Dark brown color
B. Blue color
C. Brilliant pink color (Correct Answer)
D. Khaki color

Explanation: **Explanation:** Amyloid is an extracellular proteinaceous material characterized by a **beta-pleated sheet configuration** [1]. This unique physical structure allows it to bind specifically to certain dyes. When stained with **Congo red** and viewed under ordinary transmitted light, amyloid deposits appear as a **brilliant pink or salmon-pink color** [1]. This is the gold standard for identifying amyloid in tissue sections. **Analysis of Options:** * **Option C (Correct):** Congo red dye molecules align themselves parallel to the beta-pleated fibrils of amyloid, resulting in the characteristic **brilliant pink/salmon-pink** appearance under light microscopy [1]. * **Option A (Dark Brown):** This color is typically associated with **Iodine staining** of gross specimens (Virchow’s method), where amyloid turns mahogany brown. * **Option B (Blue):** Amyloid may appear blue when treated with **Iodine followed by sulfuric acid** (grossly). In histology, blue is characteristic of Alcian Blue (mucin) or Prussian Blue (iron). * **Option D (Khaki):** This is not a standard color description for amyloid staining. **High-Yield NEET-PG Pearls:** 1. **Polarizing Microscopy:** The most diagnostic feature of Congo red-stained amyloid is **Apple-green birefringence** when viewed under polarized light [1], [2]. 2. **Metachromasia:** Amyloid shows metachromasia (shifts color) with **Methyl violet or Crystal violet**, appearing rose-pink against a blue background. 3. **Fluorescence:** **Thioflavin T or S** produces a secondary fluorescence (yellow-green) and is highly sensitive but less specific than Congo red. 4. **H&E Stain:** On standard H&E, amyloid appears as an amorphous, eosinophilic, hyaline extracellular substance [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 268-269. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Heart, pp. 580-581.

Question 1164: Which of the following tissues characteristically contains oval cells?

A. Skin
B. Cornea
C. Liver (Correct Answer)
D. Bone

Explanation: Explanation: In the context of liver pathology, **Oval cells** are the resident facultative stem cells of the liver [1]. They are located within the **Canals of Hering** (the terminal branches of the biliary tree). These cells are bipotential, meaning they have the capacity to differentiate into both **hepatocytes** and **biliary epithelial cells** (cholangiocytes). Under normal physiological conditions, liver regeneration occurs via the replication of mature hepatocytes [3]. However, when hepatocyte proliferation is inhibited or overwhelmed (e.g., in chronic liver injury, cirrhosis, or certain toxic insults), oval cells are activated and proliferate to restore liver parenchyma [1], [2]. They are morphologically characterized by their small size, scant cytoplasm, and distinctive oval-shaped nuclei. **Analysis of Incorrect Options:** * **A. Skin:** The primary regenerative cells are basal keratinocytes located in the *stratum basale* or stem cells in the hair follicle bulge [1]. * **B. Cornea:** Regeneration is driven by **Limbal stem cells** located at the corscorneral junction (limbus). * **C. Bone:** Bone contains osteoprogenitor cells (mesenchymal stem cells), osteoblasts, and osteocytes, but these are not referred to as "oval cells." **High-Yield NEET-PG Pearls:** * **Marker:** Oval cells typically express markers of both lineages, such as **CK19** (biliary) and **AFP** (hepatocytic), along with stem cell markers like **CD117 (c-kit)** and **Sca-1**. * **Niche:** The Canals of Hering are the specific anatomical niche for these cells. * **Clinical Significance:** Oval cell hyperplasia is a hallmark of chronic liver disease and is often seen in the periportal regions during the early stages of cirrhosis [2]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 104-105. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 833-834. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 112-113.

Question 1165: Caspases are involved in which of the following processes?

A. Nerve processing
B. Cell signaling
C. Inflammation
D. Apoptosis (Correct Answer)

Explanation: **Explanation:** **Caspases** (Cysteine-aspartic proteases) are the central executioners of **Apoptosis** (Programmed Cell Death) [1]. They exist as inactive zymogens (pro-caspases) and are activated through a proteolytic cleavage cascade. * **Why Apoptosis is Correct:** Caspases are categorized into **Initiators** (Caspase 8, 9, 10) and **Executioners** (Caspase 3, 6, 7) [1]. Once activated, executioner caspases (specifically **Caspase 3**) cleave structural proteins and activate DNases, leading to the characteristic nuclear fragmentation and formation of apoptotic bodies. * **Why other options are incorrect:** * **Nerve processing:** This involves neurotransmitters (e.g., Acetylcholine, Glutamate) and action potentials, not the caspase cascade. * **Cell signaling:** While caspases are part of a signaling pathway, "cell signaling" usually refers to broader processes like GPCR or Tyrosine Kinase pathways involved in growth and metabolism. * **Inflammation:** While **Caspase 1** is involved in the "Inflammasome" to process IL-1̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢̢ **High-Yield NEET-PG Pearls:** 1. **Intrinsic (Mitochondrial) Pathway:** Initiated by **Caspase 9** [1]. 2. **Extrinsic (Death Receptor) Pathway:** Initiated by **Caspase 8** or 10 [2]. 3. **Executioner Caspase:** **Caspase 3** is the common final pathway for both [1]. 4. **Caspase-independent cell death:** Includes processes like Necroptosis (involving RIPK1/RIPK3). 5. **Marker for Apoptosis:** Annexin V (binds to Phosphatidylserine flipped to the outer membrane). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 64-67. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 67.

Question 1166: What is true about senile systemic amyloidosis?

A. Systemic involvement is present
B. It is caused by AA amyloid
C. Heart failure is the predominant presentation
D. Transthyretin is the deposited protein (Correct Answer)

Explanation: **Explanation:** **Senile Systemic Amyloidosis (SSA)**, also known as Wild-Type Transthyretin Amyloidosis (ATTRwt), is a condition primarily affecting elderly individuals (typically >70 years) [3]. 1. **Why Option D is Correct:** The deposited protein in SSA is **normal (wild-type) Transthyretin (TTR)** [1]. TTR is a serum protein synthesized in the liver that transports thyroxine and retinol. With age, this protein can become unstable, misfold, and deposit as amyloid fibrils in various tissues, most significantly the heart [1]. 2. **Why Other Options are Incorrect:** * **Option A:** Despite the name "systemic," the clinical manifestations are almost exclusively limited to the **heart** [3]. While minor deposits may be found elsewhere, it does not behave like a true systemic amyloidosis (like AL or AA). * **Option B:** **AA amyloid** is associated with Chronic Inflammatory states (e.g., Rheumatoid Arthritis, TB). SSA is strictly an **ATTR** type [1][4]. * **Option C:** While it affects the heart, the presentation is typically a **restrictive cardiomyopathy** or arrhythmias [2]. While this can lead to heart failure, "Heart failure" is a general clinical syndrome; the specific hallmark of SSA is the **deposition of TTR**, making Option D the most definitive pathological fact. **NEET-PG High-Yield Pearls:** * **Staining:** Like all amyloids, it shows **Apple-green birefringence** under polarized light with Congo Red stain [4]. * **SSA vs. Familial Amyloidosis:** In SSA, the TTR is **wild-type** (normal). In Familial Amyloid Polyneuropathy, the TTR is **mutated** [1]. * **Clinical Clue:** Look for an elderly male patient with unexplained restrictive cardiomyopathy and a history of **Carpal Tunnel Syndrome** (often a precursor to cardiac symptoms in ATTR). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, p. 266. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Heart, pp. 580-581. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Heart, p. 580. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 268-269.

Question 1167: What is the pathogenesis of a periapical cyst?

A. Increased pressure within the cyst
B. Immune-mediated bone destruction
C. Proliferation of epithelium (Correct Answer)
D. None of the above

Explanation: The **periapical cyst** (also known as a radicular cyst) is the most common inflammatory odontogenic cyst. Its pathogenesis is rooted in a chronic inflammatory response following pulp necrosis. [2] **1. Why "Proliferation of epithelium" is correct:** The hallmark of periapical cyst formation is the activation of the **Rest Cells of Malassez**. These are quiescent epithelial remnants of Hertwig’s epithelial root sheath located in the periodontal ligament. When a tooth becomes non-vital due to caries or trauma, inflammation spreads to the apex. Inflammatory mediators (specifically cytokines like IL-1, IL-6, and TNF) and growth factors stimulate these dormant epithelial rests to **proliferate**, forming an epithelial mass. Eventually, the central cells of this mass lose their nutritional supply, undergo liquefactive necrosis, and create a fluid-filled cavity (the cyst). **2. Why other options are incorrect:** * **Option A (Increased pressure):** While osmotic pressure contributes to the *expansion* and enlargement of an existing cyst, it is not the initiating pathogenic mechanism. * **Option B (Immune-mediated bone destruction):** Bone resorption (via osteoclasts) occurs to accommodate the growing cyst, but this is a secondary effect of the inflammatory process, not the primary cause of the cyst's formation. [1] **High-Yield Clinical Pearls for NEET-PG:** * **Radiological Appearance:** Presents as a well-defined, unilocular radiolucency at the apex of a **non-vital (dead) tooth**. * **Histopathology:** Characterized by a lining of stratified squamous epithelium and the presence of **Rushton bodies** (eosinophilic, linear/arch-shaped inclusions). * **Cholesterol Clefts:** Often seen in the cyst wall with associated multinucleated giant cells. * **Key Difference:** If the lesion is <2cm and lacks an epithelial lining, it is a periapical granuloma; once epithelium proliferates to form a lumen, it becomes a cyst. [1] **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Head and Neck, pp. 741-742. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Head and Neck, p. 741.

Question 1168: The infarct of which of the following organs is invariably hemorrhagic?

A. Kidney
B. Lung (Correct Answer)
C. Spleen
D. Heart

Explanation: ### Explanation **Correct Answer: B. Lung** The fundamental concept behind this question is the classification of infarcts into **Red (Hemorrhagic)** and **White (Anemic)** [2]. **Why the Lung is the correct answer:** Hemorrhagic infarcts occur in tissues with a **dual blood supply** or loose, spongy textures [2]. The lung receives blood from both the **Pulmonary arteries** and the **Bronchial arteries** [1]. When a pulmonary artery branch is occluded, the tissue becomes necrotic, but the bronchial circulation continues to pump blood into the necrotic area [1]. Because the lung tissue is lax/spongy, it cannot contain the pressure, leading to extensive hemorrhage into the infarcted zone [1],[2]. **Why the other options are incorrect:** * **A. Kidney:** This is a solid organ with **end-artery circulation**. Occlusion leads to a **White (Anemic) infarct**, as there is no secondary blood supply to bleed into the necrotic area [2]. * **C. Spleen:** Like the kidney, the spleen is a solid organ with a single arterial supply, resulting in wedge-shaped white infarcts [2]. * **D. Heart:** Myocardial infarction is typically a white infarct [2]. While some secondary hemorrhage can occur during reperfusion, the primary infarct in a solid organ like the heart is considered "white." **High-Yield NEET-PG Pearls:** 1. **Red Infarcts (Hemorrhagic):** Occur in lungs, GI tract (dual supply/collaterals), tissues with venous occlusion (e.g., Testicular torsion), and loose tissues [2]. 2. **White Infarcts (Anemic):** Occur in solid organs with end-arterial circulation (Heart, Spleen, Kidney) [2]. 3. **Morphology:** Most infarcts are **wedge-shaped**, with the apex pointing toward the occluded vessel [2]. 4. **Microscopy:** The characteristic hallmark of most infarcts (except the brain) is **Ischemic Coagulative Necrosis**. The brain undergoes Liquefactive Necrosis [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, pp. 137-138. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, p. 140. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 148-149.

Question 1169: What is the characteristic feature of apoptosis on light microscopy?

A. Cellular swelling
B. Nuclear compaction
C. Intact cell membrane (Correct Answer)
D. Cytoplasmic eosinophilia

Explanation: **Explanation:** Apoptosis, or programmed cell death, is a highly regulated process designed to eliminate unwanted cells without eliciting an inflammatory response [1]. **1. Why "Intact cell membrane" is correct:** The hallmark of apoptosis is that the **plasma membrane remains intact** throughout the process [1]. Unlike necrosis, where the membrane ruptures and spills cellular contents (triggering inflammation), apoptotic cells undergo structural reorganization. The cell shrinks and buds into "apoptotic bodies" which are enclosed by a membrane [1]. This prevents the leakage of enzymes and explains why apoptosis does **not** cause inflammation [2]. **2. Why other options are incorrect:** * **Cellular swelling (A):** This is a feature of **Necrosis** (oncosis) and reversible cell injury [3]. In apoptosis, the cell actually undergoes **shrinkage**. * **Nuclear compaction (B):** While chromatin condensation (pyknosis) occurs in apoptosis, "Nuclear compaction" is a less specific term. Furthermore, the preservation of the membrane is the most defining *characteristic* feature that distinguishes it from other forms of cell death on microscopy. * **Cytoplasmic eosinophilia (D):** This is seen in both apoptosis and necrosis (due to loss of cytoplasmic RNA and denatured proteins). It is not a unique or defining feature of apoptosis. **NEET-PG High-Yield Pearls:** * **Most characteristic morphological feature:** Chromatin condensation (Pyknosis). * **Gold Standard for detection:** TUNEL assay (detects DNA fragmentation). * **Step-ladder pattern:** Seen on DNA electrophoresis due to internucleosomal cleavage by endonucleases (180–200 base pair fragments). * **Biomarker:** Annexin V (binds to Phosphatidylserine, which flips to the outer membrane leaflet). * **Caspases:** These are cysteine proteases that serve as the "executioners" of apoptosis. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 63-64. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 67-69. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 51-53.

Question 1170: Preformed antibodies cause which type of transplant rejection?

A. Hyperacute rejection (Correct Answer)
B. Acute rejection
C. Chronic rejection
D. Acute humoral rejection

Explanation: ### Explanation **Correct Answer: A. Hyperacute rejection** **Why it is correct:** Hyperacute rejection is a **Type II hypersensitivity reaction** mediated by **preformed antibodies** (humoral immunity) present in the recipient's circulation [1]. These antibodies are typically directed against ABO blood group antigens or HLA antigens (due to prior blood transfusions, pregnancies, or previous transplants) [3]. * **Mechanism:** Once the donor organ is anastomosed, these antibodies immediately bind to the vascular endothelium, activating the **complement system**. This leads to rapid endothelial injury, fibrin-platelet thrombi formation, and ischemic necrosis [1]. * **Timeline:** It occurs within **minutes to hours** of transplantation and is often visible to the surgeon as the organ turns cyanotic and mottled on the operating table [1]. **Why the other options are incorrect:** * **B. Acute Rejection:** Occurs within days to weeks [1]. It is primarily **cell-mediated (Type IV)** involving CD8+ T-cells (Acute Cellular Rejection), though it can have a humoral component [2]. It is not caused by *preformed* antibodies but by a primary immune response to the graft. * **C. Chronic Rejection:** Occurs months to years post-transplant. It is characterized by **intimal thickening and fibrosis** (accelerated graft arteriosclerosis). It involves a slow, progressive immune-mediated injury (both cellular and humoral). * **D. Acute Humoral Rejection:** Also known as Acute Antibody-Mediated Rejection (AMR). While it involves antibodies, these are usually **newly formed** (de novo) post-transplant, not preformed. **NEET-PG High-Yield Pearls:** * **Morphology:** Hyperacute rejection is characterized by **"Fibrinoid necrosis"** of arterial walls and widespread microvascular thrombosis [1]. * **Prevention:** It is prevented by **Cross-matching** (testing recipient serum against donor lymphocytes) and ABO blood grouping [3]. * **Key Histology:** In Acute Cellular Rejection, look for **"Endotheliitis"** (lymphocytes under the endothelium) and interstitial inflammatory infiltrates [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 241-242. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, p. 242. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 179-180.

Practice by Chapter

Cell Injury and Cell Death

Practice Questions

Adaptations of Cellular Growth

Practice Questions

Accumulations and Deposits

Practice Questions

Acute and Chronic Inflammation

Practice Questions

Tissue Repair and Wound Healing

Practice Questions

Hemodynamic Disorders

Practice Questions

Genetic Disorders

Practice Questions

Environmental Pathology

Practice Questions

Nutritional Diseases

Practice Questions

Molecular Basis of Disease

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free